2 weeks Ago Video content above is prompted by the following: What are the advantages and limitations of outpatient administration? In your opinion, how can any issues with outpatient administration be addressed?.
Top
The Future of CAR T-Cell Therapy in R/R DLBCL: Closing Reflections and Key Takeaways
Experts discuss the future outlook for chimeric antigen receptor T-cell therapy (CAR T) in diffuse large B-cell therapy (DLBCL), exploring potential advancements and evolving treatment strategies.
2 weeks Ago 
